Skip to Content

Drug interactions between Stamaril and Vivaglobin

Results for the following 2 drugs:
Stamaril (yellow fever vaccine)
Vivaglobin (immune globulin subcutaneous)

Interactions between your drugs


yellow fever vaccine immune globulin subcutaneous

Applies to: Stamaril (yellow fever vaccine) and Vivaglobin (immune globulin subcutaneous)

Immune globulin subcutaneous may interfere with the immune response to yellow fever vaccine. A person who has been treated with immune globulin subcutaneous should generally not be vaccinated for several months with a live vaccine. If vaccination was given shortly before or after immune globulin subcutaneous, a revaccination may be necessary. The immunizing doctor should be informed of recent therapy with immune globulin subcutaneous so that appropriate measures and/or precautions can be taken. It is important to tell the doctor about all other medications being used, including vitamins and herbs. Do not stop using any medications without first talking to the doctor.

Switch to professional interaction data

Drug and food interactions

No results found in our database - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.